EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 20-Jun-2026 11:15 ET (20-Jun-2026 15:15 GMT/UTC)

Researchers find rare mutation doesn’t always result in blood cancer

North Carolina State University
Peer-Reviewed Publication

Researchers have found that a genetic mutation associated with a rare group of blood cancers does not always result in development of the disease.

Journal: Proceedings of the National Academy of Sciences

A new approach in anticancer vaccine development shows early success in targeting neuroblastoma

RCSI
Peer-Reviewed Publication

A new study from RCSI University of Medicine and Health Sciences demonstrates a novel approach in anticancer vaccine development. Results present the first preclinical evidence to show the efficacy of an mRNA vaccine in targeting neuroblastoma, the deadliest childhood cancer.

Journal: Molecular Therapy Oncology

Lab-on-a-chip platform shows how immune cells attack cancer cells

Technical University of Munich (TUM)
Peer-Reviewed Publication

Immunotherapies are a promising approach in the fight against cancer. Researchers at the Technical University of Munich (TUM) have developed a lab-on-a-chip system called CellTrap. It makes it possible to observe the interactions between immune cells and cancer cells at the single-cell level. The method is intended to help better understand fundamental processes in cancer immunology and answer key questions.

Journal: RSC Advances

Researchers find caregivers of children hospitalized for cancer, blood disorders at risk for food insecurity

Wake Forest University School of Medicine
Peer-Reviewed Publication

A study by Wake Forest University School of medicine researchers highlights an overlooked issue, “inpatient food insecurity,” or when families don’t have enough to eat while their child is in the hospital because of the hardships that time might create like missed work or additional expenses.

Journal: Pediatric Blood & Cancer

AI model proves to be a heavyweight in tumor assessment: Mesothelioma patients and physicians benefit

Netherlands Cancer Institute
Peer-Reviewed Publication

Physicians and researchers at the Netherlands Cancer Institute have developed an AI model that outperforms physicians at evaluating treatment response in pleural mesothelioma. Being far more accurate than the current international standard criteria (RECIST), the model provides patients with greater certainty and tailored treatments. It radically changes how physicians assess tumors and could accelerate the development of new treatments by making clinical trials more reliable and efficient.

Journal: The Lancet Oncology
Funder: KWF Kankerbestrijding, AVL Foundation, Nederlandse Vereniging van Artsen voor Longziekten en Tuberculose

AGA: Colonoscopy remains the top choice for colorectal cancer screening amid new guidance

American Gastroenterological Association
Business Announcement

As new colorectal cancer screening guidance draws attention to the growing number of testing options, the American Gastroenterological Association urges patients and primary care providers to understand how those options compare. AGA experts emphasize that screening saves lives — and that the type of test matters.

Radiation therapy enhances immune environment in brain metastases, improving treatment response

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

A new study led by researchers at The University of Texas MD Anderson Cancer Center demonstrated that pre-operative radiation therapy for brain metastases not only targets tumor cells directly but also can activate immune pathways that can make tumors more receptive to immunotherapy.

Journal: Clinical Cancer Research

St. Jude redesignated as WHO Collaborating Centre for Childhood Cancer

St. Jude Children's Research Hospital
Business Announcement

Redesignation as the only WHO Collaborating Centre dedicated to pediatric cancer demonstrates shared commitment in advancing childhood cancer care together globally

Lifestyle factors may influence prostate cancer risk in Indian men

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY — June 17, 2026 — A new research paper was published in Volume 13 of Oncoscience on April 28, 2026, titled “Modifiable risk factors of prostate cancer: Insights from a hospital-based study.”

Journal: Oncoscience

U of Guelph prof discovers plant-based solution to target leukemia weakness

University of Guelph
Peer-Reviewed Publication

New University of Guelph research published in the renowned hematology publication Blood has uncovered a surprising weakness in acute myeloid leukemia (AML) that a compound in a common skincare ingredient may be able to target.

Journal: Blood
Funder: University of Guelph

1
2
3
4